Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1h4
|
ENSMUSG00000047638.9 | nuclear receptor subfamily 1, group H, member 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_89519354_89519516 | Nr1h4 | 12777 | 0.205607 | 0.73 | 2.0e-10 | Click! |
chr10_89518420_89518571 | Nr1h4 | 11837 | 0.208362 | 0.70 | 2.3e-09 | Click! |
chr10_89506578_89506769 | Nr1h4 | 15 | 0.982218 | 0.68 | 1.3e-08 | Click! |
chr10_89483839_89484059 | Nr1h4 | 22700 | 0.191723 | 0.60 | 1.4e-06 | Click! |
chr10_89532098_89532252 | Nr1h4 | 1410 | 0.449298 | 0.58 | 2.9e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_25628698_25629047 | 36.90 |
Fcna |
ficolin A |
842 |
0.28 |
chr1_33630885_33631502 | 31.20 |
Prim2 |
DNA primase, p58 subunit |
7869 |
0.14 |
chr8_119432614_119432809 | 28.54 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
1413 |
0.35 |
chr19_4594162_4594488 | 24.18 |
Pcx |
pyruvate carboxylase |
21 |
0.96 |
chr11_32285702_32285899 | 23.91 |
Hbq1b |
hemoglobin, theta 1B |
1165 |
0.29 |
chr1_180902923_180903097 | 23.75 |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
1283 |
0.27 |
chr7_142568972_142569582 | 23.27 |
H19 |
H19, imprinted maternally expressed transcript |
7261 |
0.1 |
chr2_84938318_84938544 | 23.21 |
Slc43a3 |
solute carrier family 43, member 3 |
1541 |
0.28 |
chr8_94962299_94962469 | 21.46 |
Gm10286 |
predicted gene 10286 |
7370 |
0.12 |
chr6_82088207_82088404 | 20.56 |
Gm15864 |
predicted gene 15864 |
35724 |
0.14 |
chr1_195113589_195113946 | 20.26 |
Cr1l |
complement component (3b/4b) receptor 1-like |
3874 |
0.16 |
chr1_86406983_86407186 | 19.48 |
Nmur1 |
neuromedin U receptor 1 |
8894 |
0.1 |
chr11_120630519_120630818 | 19.16 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
32 |
0.91 |
chr2_167416107_167416468 | 18.10 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
5425 |
0.2 |
chr11_70822348_70822640 | 17.85 |
Scimp |
SLP adaptor and CSK interacting membrane protein |
9908 |
0.11 |
chr1_131126323_131126498 | 17.66 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
11835 |
0.13 |
chr5_119332701_119332857 | 17.45 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
35534 |
0.21 |
chr4_133557474_133557769 | 17.44 |
Gm23158 |
predicted gene, 23158 |
1328 |
0.26 |
chr18_20936467_20936777 | 17.38 |
Rnf125 |
ring finger protein 125 |
8003 |
0.21 |
chr6_124646614_124646788 | 17.19 |
C1s2 |
complement component 1, s subcomponent 2 |
10616 |
0.09 |
chr1_130731762_130732102 | 17.10 |
AA986860 |
expressed sequence AA986860 |
44 |
0.94 |
chr2_170459761_170460089 | 17.09 |
Gm14269 |
predicted gene 14269 |
3894 |
0.19 |
chr8_35564370_35564526 | 16.99 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
23350 |
0.16 |
chr1_36090745_36091181 | 16.83 |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
10727 |
0.14 |
chr12_12452227_12452403 | 16.69 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
59700 |
0.14 |
chr5_116023179_116023683 | 16.69 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
925 |
0.45 |
chr11_79753220_79753373 | 16.40 |
Mir365-2 |
microRNA 365-2 |
26896 |
0.12 |
chr8_45281703_45281995 | 16.34 |
Klkb1 |
kallikrein B, plasma 1 |
13010 |
0.15 |
chr11_75462325_75462847 | 16.29 |
Tlcd2 |
TLC domain containing 2 |
871 |
0.25 |
chr5_64435595_64435902 | 16.28 |
Gm31363 |
predicted gene, 31363 |
1793 |
0.27 |
chr11_35732476_35732633 | 16.05 |
Pank3 |
pantothenate kinase 3 |
36930 |
0.14 |
chr1_164526906_164527057 | 15.89 |
Gm26685 |
predicted gene, 26685 |
23672 |
0.14 |
chr12_80083901_80084242 | 15.84 |
Gm36660 |
predicted gene, 36660 |
2637 |
0.2 |
chr9_103241324_103241486 | 15.78 |
Trf |
transferrin |
10961 |
0.16 |
chr11_69946375_69946696 | 15.75 |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
1439 |
0.15 |
chr1_191855059_191855511 | 15.65 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
28137 |
0.12 |
chr2_181253341_181253492 | 15.62 |
Gmeb2 |
glucocorticoid modulatory element binding protein 2 |
2715 |
0.14 |
chr18_74729984_74730217 | 15.60 |
Myo5b |
myosin VB |
3665 |
0.23 |
chr4_49485826_49485977 | 15.60 |
Gm26424 |
predicted gene, 26424 |
11594 |
0.12 |
chr2_169351742_169351893 | 15.52 |
Gm14250 |
predicted gene 14250 |
37264 |
0.17 |
chr2_25485377_25485554 | 15.45 |
Lcn12 |
lipocalin 12 |
7967 |
0.07 |
chr13_37715025_37715360 | 15.38 |
Gm40918 |
predicted gene, 40918 |
1119 |
0.39 |
chr7_4743413_4743709 | 15.36 |
Kmt5c |
lysine methyltransferase 5C |
817 |
0.36 |
chr1_170516187_170516826 | 15.33 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
40604 |
0.16 |
chr4_136214938_136215135 | 15.32 |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
8671 |
0.14 |
chr16_91239043_91239344 | 14.87 |
Olig2 |
oligodendrocyte transcription factor 2 |
13736 |
0.11 |
chr3_79721203_79721372 | 14.83 |
Rxfp1 |
relaxin/insulin-like family peptide receptor 1 |
16507 |
0.17 |
chr3_121378778_121378962 | 14.80 |
Gm5711 |
predicted gene 5711 |
1809 |
0.31 |
chr1_170622997_170623376 | 14.79 |
Gm7299 |
predicted gene 7299 |
7735 |
0.19 |
chr11_102365077_102365683 | 14.74 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
100 |
0.94 |
chr11_95808504_95808830 | 14.72 |
Phospho1 |
phosphatase, orphan 1 |
15832 |
0.1 |
chr5_91961353_91961685 | 14.64 |
Thap6 |
THAP domain containing 6 |
870 |
0.36 |
chr16_56068127_56068298 | 14.55 |
Gm24047 |
predicted gene, 24047 |
2351 |
0.19 |
chr18_59087649_59087800 | 14.54 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
25213 |
0.24 |
chr2_119155328_119155687 | 14.53 |
Rmdn3 |
regulator of microtubule dynamics 3 |
1317 |
0.28 |
chr3_127929993_127930179 | 14.51 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
13914 |
0.14 |
chr2_6331309_6331868 | 14.48 |
AL845275.1 |
novel protein |
8508 |
0.19 |
chr11_107337371_107337788 | 14.38 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
53 |
0.88 |
chr9_66182054_66182393 | 14.22 |
Dapk2 |
death-associated protein kinase 2 |
23988 |
0.17 |
chr2_26600073_26600434 | 14.10 |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) |
3463 |
0.11 |
chr4_106248411_106248570 | 14.07 |
Gm12724 |
predicted gene 12724 |
7274 |
0.16 |
chr13_43231981_43232458 | 13.69 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr17_57233114_57233482 | 13.48 |
C3 |
complement component 3 |
5162 |
0.12 |
chr1_193544054_193544208 | 13.45 |
Mir205hg |
Mir205 host gene |
33957 |
0.14 |
chr5_108674685_108675069 | 13.37 |
Slc26a1 |
solute carrier family 26 (sulfate transporter), member 1 |
92 |
0.94 |
chr11_98580607_98580818 | 13.35 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
6656 |
0.11 |
chr18_11317630_11317906 | 13.28 |
Gata6 |
GATA binding protein 6 |
258721 |
0.02 |
chr10_21268752_21269068 | 13.25 |
Gm33728 |
predicted gene, 33728 |
16796 |
0.14 |
chr17_12185970_12186143 | 13.22 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
3865 |
0.23 |
chr11_116077472_116077863 | 13.17 |
Unc13d |
unc-13 homolog D |
43 |
0.95 |
chr7_115845008_115845308 | 13.11 |
Sox6 |
SRY (sex determining region Y)-box 6 |
947 |
0.7 |
chr14_30923538_30923703 | 13.04 |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
33 |
0.96 |
chr4_150745963_150746359 | 13.03 |
Gm16079 |
predicted gene 16079 |
67369 |
0.09 |
chr15_95883474_95883993 | 12.92 |
Gm25070 |
predicted gene, 25070 |
3916 |
0.23 |
chr1_84851610_84851763 | 12.84 |
Trip12 |
thyroid hormone receptor interactor 12 |
11170 |
0.14 |
chr2_64973944_64974095 | 12.78 |
Grb14 |
growth factor receptor bound protein 14 |
1727 |
0.5 |
chr5_100608061_100608215 | 12.57 |
Gm43510 |
predicted gene 43510 |
15382 |
0.14 |
chr16_24089992_24090308 | 12.55 |
Gm31583 |
predicted gene, 31583 |
61 |
0.97 |
chr16_90988029_90988399 | 12.54 |
Gm15965 |
predicted gene 15965 |
4307 |
0.12 |
chr1_67077762_67078048 | 12.51 |
Lancl1 |
LanC (bacterial lantibiotic synthetase component C)-like 1 |
39033 |
0.15 |
chr19_14259408_14259559 | 12.35 |
Gm26993 |
predicted gene, 26993 |
241112 |
0.02 |
chr1_164415751_164415906 | 12.34 |
Gm37411 |
predicted gene, 37411 |
8885 |
0.16 |
chr1_184645062_184645232 | 12.33 |
Gm37800 |
predicted gene, 37800 |
15674 |
0.15 |
chr13_101552934_101553307 | 12.29 |
Gm19010 |
predicted gene, 19010 |
4711 |
0.18 |
chr14_21096913_21097064 | 12.29 |
Adk |
adenosine kinase |
20836 |
0.2 |
chr2_61970046_61970617 | 12.26 |
Gm13555 |
predicted gene 13555 |
341 |
0.92 |
chr16_18711811_18711962 | 12.21 |
Rps2-ps7 |
ribosomal protein S2, pseudogene 7 |
29670 |
0.13 |
chr4_133552955_133553552 | 12.20 |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
123 |
0.92 |
chr13_111957786_111958005 | 12.18 |
Gm15322 |
predicted gene 15322 |
33571 |
0.14 |
chr10_81091818_81091969 | 12.13 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
13 |
0.94 |
chr16_26706594_26706745 | 12.10 |
Il1rap |
interleukin 1 receptor accessory protein |
15765 |
0.25 |
chr5_8928690_8928841 | 12.08 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
39 |
0.97 |
chr2_167319069_167319276 | 12.02 |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
5272 |
0.2 |
chr17_31930001_31930260 | 11.96 |
Gm30571 |
predicted gene, 30571 |
17464 |
0.12 |
chr1_51720253_51720412 | 11.92 |
Gm28055 |
predicted gene 28055 |
22432 |
0.19 |
chr5_108483140_108483295 | 11.90 |
Pcgf3 |
polycomb group ring finger 3 |
3003 |
0.16 |
chr13_45089081_45089254 | 11.88 |
Hsp25-ps1 |
heat shock protein 25, pseudogene 1 |
10040 |
0.16 |
chr2_181497282_181497794 | 11.86 |
Tpd52l2 |
tumor protein D52-like 2 |
307 |
0.81 |
chr14_34357713_34358023 | 11.85 |
Fam25c |
family with sequence similarity 25, member C |
2435 |
0.17 |
chr2_132103366_132103560 | 11.84 |
Gm14052 |
predicted gene 14052 |
3594 |
0.21 |
chr8_86594577_86594760 | 11.79 |
Gm44348 |
predicted gene, 44348 |
7706 |
0.18 |
chr11_98583119_98583444 | 11.78 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
4087 |
0.12 |
chr16_18429173_18429401 | 11.75 |
Txnrd2 |
thioredoxin reductase 2 |
362 |
0.76 |
chr8_119430254_119430609 | 11.75 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
3693 |
0.18 |
chr1_74001484_74001792 | 11.74 |
Tns1 |
tensin 1 |
71 |
0.98 |
chrX_170676731_170676882 | 11.67 |
Asmt |
acetylserotonin O-methyltransferase |
4162 |
0.34 |
chr16_32453210_32453401 | 11.67 |
2210020O09Rik |
RIKEN cDNA 2210020O09 gene |
2844 |
0.17 |
chr3_123104431_123104729 | 11.65 |
Synpo2 |
synaptopodin 2 |
8230 |
0.16 |
chr4_105261004_105261461 | 11.64 |
Plpp3 |
phospholipid phosphatase 3 |
103885 |
0.07 |
chr2_69342609_69342760 | 11.64 |
Abcb11 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
68 |
0.97 |
chr9_65422857_65423043 | 11.61 |
Slc51b |
solute carrier family 51, beta subunit |
5 |
0.95 |
chr9_44802879_44803044 | 11.59 |
Ttc36 |
tetratricopeptide repeat domain 36 |
111 |
0.91 |
chr14_31182806_31183030 | 11.58 |
Nisch |
nischarin |
89 |
0.95 |
chr12_55436869_55437028 | 11.55 |
Psma6 |
proteasome subunit alpha 6 |
29565 |
0.14 |
chr7_101064633_101064988 | 11.54 |
Gm5735 |
predicted gene 5735 |
3335 |
0.2 |
chr11_87754992_87755208 | 11.54 |
Mir142hg |
Mir142 host gene (non-protein coding) |
477 |
0.58 |
chr4_115059412_115059621 | 11.49 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
8 |
0.97 |
chr3_142707074_142707309 | 11.44 |
Kyat3 |
kynurenine aminotransferase 3 |
6097 |
0.15 |
chr2_158306786_158306984 | 11.43 |
Lbp |
lipopolysaccharide binding protein |
273 |
0.86 |
chr6_72778840_72779003 | 11.41 |
Tcf7l1 |
transcription factor 7 like 1 (T cell specific, HMG box) |
9677 |
0.17 |
chr4_150804310_150804509 | 11.39 |
Gm13049 |
predicted gene 13049 |
21324 |
0.15 |
chr13_58067512_58068080 | 11.38 |
Klhl3 |
kelch-like 3 |
34632 |
0.13 |
chr3_102165328_102165722 | 11.37 |
Vangl1 |
VANGL planar cell polarity 1 |
415 |
0.79 |
chr1_161750684_161751022 | 11.34 |
Gm5049 |
predicted gene 5049 |
4797 |
0.17 |
chr18_65095695_65095995 | 11.34 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
12791 |
0.24 |
chr10_93069058_93069363 | 11.31 |
Cfap54 |
cilia and flagella associated protein 54 |
1041 |
0.57 |
chr10_40125174_40125635 | 11.29 |
Gm25613 |
predicted gene, 25613 |
15942 |
0.13 |
chr18_10413569_10413937 | 11.29 |
Greb1l |
growth regulation by estrogen in breast cancer-like |
44472 |
0.12 |
chr2_156720289_156721547 | 11.22 |
4930405A21Rik |
RIKEN cDNA 4930405A21 gene |
9 |
0.6 |
chr11_98581366_98581517 | 11.20 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5927 |
0.11 |
chr4_135404998_135405186 | 11.18 |
Gm12990 |
predicted gene 12990 |
1436 |
0.24 |
chr17_28760834_28761039 | 11.17 |
Mapk13 |
mitogen-activated protein kinase 13 |
8361 |
0.12 |
chr9_124138054_124138419 | 11.14 |
Ccr5 |
chemokine (C-C motif) receptor 5 |
9488 |
0.21 |
chr11_116506385_116506879 | 11.14 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr10_128201879_128202055 | 11.10 |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
1289 |
0.22 |
chr11_120353462_120354038 | 11.10 |
0610009L18Rik |
RIKEN cDNA 0610009L18 gene |
5072 |
0.09 |
chr7_28596265_28596676 | 11.07 |
Pak4 |
p21 (RAC1) activated kinase 4 |
1616 |
0.18 |
chr12_59093694_59093845 | 11.05 |
Rpl21-ps3 |
ribosomal protein L21, pseudogene 3 |
768 |
0.48 |
chr2_154389998_154390548 | 11.05 |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
17263 |
0.15 |
chr2_126575770_126576023 | 11.03 |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
11136 |
0.18 |
chr11_84017138_84017302 | 11.03 |
Synrg |
synergin, gamma |
1981 |
0.33 |
chr11_4676898_4677289 | 11.01 |
Uqcr10 |
ubiquinol-cytochrome c reductase, complex III subunit X |
26960 |
0.11 |
chr14_70336335_70336839 | 10.97 |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
2389 |
0.19 |
chr17_59012796_59013456 | 10.94 |
Nudt12 |
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
142 |
0.96 |
chr18_8966820_8967020 | 10.93 |
Gm7523 |
predicted gene 7523 |
824 |
0.71 |
chr13_91741343_91741957 | 10.92 |
Acot12 |
acyl-CoA thioesterase 12 |
117 |
0.5 |
chr15_100111990_100112211 | 10.91 |
4930478M13Rik |
RIKEN cDNA 4930478M13 gene |
3939 |
0.18 |
chr1_160044783_160045062 | 10.86 |
4930523C07Rik |
RIKEN cDNA 4930523C07 gene |
475 |
0.52 |
chr2_70830235_70830522 | 10.85 |
Tlk1 |
tousled-like kinase 1 |
4650 |
0.23 |
chr5_81568777_81568928 | 10.81 |
Gm43084 |
predicted gene 43084 |
33126 |
0.22 |
chr16_4829416_4829582 | 10.79 |
4930562C15Rik |
RIKEN cDNA 4930562C15 gene |
5917 |
0.14 |
chr15_78417017_78417333 | 10.77 |
Gm36644 |
predicted gene, 36644 |
7018 |
0.09 |
chr11_15838707_15838916 | 10.77 |
Gm37319 |
predicted gene, 37319 |
198982 |
0.03 |
chr13_62908154_62908567 | 10.69 |
Fbp1 |
fructose bisphosphatase 1 |
20078 |
0.13 |
chr18_36703277_36703432 | 10.68 |
E230025N22Rik |
Riken cDNA E230025N22 gene |
7429 |
0.08 |
chr2_152806174_152806420 | 10.66 |
Bcl2l1 |
BCL2-like 1 |
22238 |
0.11 |
chr19_5849822_5850109 | 10.63 |
Frmd8os |
FERM domain containing 8, opposite strand |
1457 |
0.19 |
chr7_98103362_98104288 | 10.58 |
Myo7a |
myosin VIIA |
464 |
0.82 |
chr15_68176469_68176706 | 10.56 |
Zfat |
zinc finger and AT hook domain containing |
82200 |
0.09 |
chr6_87790390_87790726 | 10.51 |
Rab43 |
RAB43, member RAS oncogene family |
483 |
0.59 |
chr3_31129884_31130050 | 10.46 |
Cldn11 |
claudin 11 |
19953 |
0.18 |
chrX_12322591_12322742 | 10.46 |
Gm14635 |
predicted gene 14635 |
22556 |
0.24 |
chr11_106324879_106325283 | 10.46 |
Cd79b |
CD79B antigen |
10319 |
0.11 |
chr1_55946905_55947229 | 10.44 |
Gm36986 |
predicted gene, 36986 |
13689 |
0.22 |
chr9_14363632_14363868 | 10.43 |
Endod1 |
endonuclease domain containing 1 |
17233 |
0.11 |
chr17_71088861_71089017 | 10.41 |
Myom1 |
myomesin 1 |
2543 |
0.25 |
chr9_107974575_107974737 | 10.40 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
849 |
0.29 |
chr15_58986844_58987037 | 10.38 |
4930544F09Rik |
RIKEN cDNA 4930544F09 gene |
2804 |
0.23 |
chr9_78532172_78532353 | 10.37 |
Gm47430 |
predicted gene, 47430 |
11716 |
0.13 |
chr2_140772877_140773180 | 10.36 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
101559 |
0.08 |
chr1_36920779_36920988 | 10.32 |
Gm38115 |
predicted gene, 38115 |
4344 |
0.16 |
chr8_122319734_122319919 | 10.29 |
Zfpm1 |
zinc finger protein, multitype 1 |
12506 |
0.12 |
chr2_172261099_172261318 | 10.29 |
Mc3r |
melanocortin 3 receptor |
12716 |
0.17 |
chr3_144201827_144203140 | 10.26 |
Lmo4 |
LIM domain only 4 |
87 |
0.97 |
chr11_78074361_78074827 | 10.25 |
Mir451b |
microRNA 451b |
1353 |
0.16 |
chr11_58353112_58353501 | 10.25 |
Sh3bp5l |
SH3 binding domain protein 5 like |
7994 |
0.1 |
chr11_31885877_31886028 | 10.20 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
12677 |
0.2 |
chr11_87754644_87754952 | 10.15 |
Mir142hg |
Mir142 host gene (non-protein coding) |
779 |
0.38 |
chr3_60602746_60603521 | 10.15 |
Mbnl1 |
muscleblind like splicing factor 1 |
405 |
0.79 |
chrX_168673064_168674616 | 10.13 |
Msl3 |
MSL complex subunit 3 |
58 |
0.98 |
chr5_130022478_130022629 | 10.10 |
Asl |
argininosuccinate lyase |
1747 |
0.24 |
chr14_57756400_57756551 | 10.10 |
Lats2 |
large tumor suppressor 2 |
1913 |
0.23 |
chr5_103744552_103744729 | 10.09 |
Aff1 |
AF4/FMR2 family, member 1 |
9522 |
0.21 |
chr4_154542026_154542259 | 10.09 |
Gm13133 |
predicted gene 13133 |
8140 |
0.18 |
chr14_76817069_76817629 | 10.07 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr3_89390311_89391266 | 10.07 |
Gm15417 |
predicted gene 15417 |
1062 |
0.22 |
chr7_119860279_119860524 | 10.01 |
Dcun1d3 |
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
1403 |
0.35 |
chr8_120744463_120744793 | 10.00 |
Irf8 |
interferon regulatory factor 8 |
852 |
0.55 |
chr15_59047713_59048081 | 9.99 |
Mtss1 |
MTSS I-BAR domain containing 1 |
7300 |
0.23 |
chr6_29697217_29697398 | 9.96 |
Tspan33 |
tetraspanin 33 |
3073 |
0.23 |
chr16_38288968_38289121 | 9.95 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
5780 |
0.15 |
chr6_94357634_94357958 | 9.94 |
Gm19908 |
predicted gene, 19908 |
8262 |
0.21 |
chr16_4029676_4029861 | 9.93 |
Dnase1 |
deoxyribonuclease I |
7174 |
0.1 |
chr4_150685197_150685518 | 9.91 |
Gm16079 |
predicted gene 16079 |
6565 |
0.21 |
chr10_127776045_127776415 | 9.89 |
Rdh9 |
retinol dehydrogenase 9 |
156 |
0.9 |
chr4_43964689_43964890 | 9.89 |
Glipr2 |
GLI pathogenesis-related 2 |
7097 |
0.14 |
chr16_92487174_92487325 | 9.85 |
Clic6 |
chloride intracellular channel 6 |
1513 |
0.32 |
chr1_134742054_134742220 | 9.78 |
Syt2 |
synaptotagmin II |
6440 |
0.17 |
chr3_95905128_95905691 | 9.76 |
Car14 |
carbonic anhydrase 14 |
718 |
0.44 |
chr10_39432725_39432913 | 9.72 |
Gm6963 |
predicted gene 6963 |
7823 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 21.6 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
6.1 | 18.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.7 | 17.0 | GO:0002432 | granuloma formation(GO:0002432) |
5.5 | 27.4 | GO:0046618 | drug export(GO:0046618) |
5.4 | 27.0 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
4.2 | 16.8 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
3.9 | 11.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
3.8 | 15.0 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
3.5 | 13.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
3.4 | 10.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.2 | 12.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
2.9 | 14.4 | GO:0019532 | oxalate transport(GO:0019532) |
2.7 | 8.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.6 | 7.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.5 | 7.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
2.4 | 9.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.4 | 14.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.3 | 6.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.2 | 13.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
2.2 | 6.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.2 | 19.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
2.2 | 10.9 | GO:0015886 | heme transport(GO:0015886) |
2.1 | 8.6 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
2.1 | 8.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.1 | 4.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.1 | 8.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.1 | 6.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.1 | 10.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
2.1 | 6.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.9 | 5.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.9 | 5.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.9 | 5.8 | GO:0032439 | endosome localization(GO:0032439) |
1.9 | 9.6 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
1.9 | 7.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.9 | 7.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.9 | 3.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.9 | 7.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.9 | 11.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.8 | 5.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.8 | 5.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.8 | 7.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.8 | 8.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.8 | 8.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.8 | 8.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.7 | 8.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.7 | 1.7 | GO:0070627 | ferrous iron import(GO:0070627) |
1.7 | 5.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.7 | 5.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.7 | 8.3 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
1.7 | 10.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.7 | 5.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.6 | 3.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.6 | 6.6 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
1.6 | 4.9 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.6 | 11.2 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
1.6 | 3.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.6 | 4.8 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.6 | 4.8 | GO:0000087 | mitotic M phase(GO:0000087) |
1.6 | 4.7 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.6 | 7.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.6 | 1.6 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.5 | 10.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.5 | 6.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.5 | 4.6 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.5 | 4.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.5 | 9.1 | GO:0048069 | eye pigmentation(GO:0048069) |
1.5 | 13.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.5 | 4.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.5 | 7.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.5 | 6.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.5 | 7.4 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.5 | 4.4 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.5 | 4.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.5 | 4.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.5 | 7.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.5 | 7.3 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.5 | 4.4 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.4 | 5.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.4 | 8.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.4 | 4.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.4 | 5.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.4 | 1.4 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.4 | 5.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.4 | 23.9 | GO:0042730 | fibrinolysis(GO:0042730) |
1.4 | 4.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.4 | 5.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.4 | 2.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.4 | 6.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.4 | 4.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.4 | 4.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.4 | 4.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.4 | 4.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
1.4 | 4.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.3 | 6.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.3 | 9.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.3 | 4.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.3 | 1.3 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.3 | 3.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.3 | 5.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.3 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.3 | 3.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.3 | 2.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.3 | 6.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.3 | 22.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
1.2 | 10.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.2 | 5.0 | GO:0008228 | opsonization(GO:0008228) |
1.2 | 13.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.2 | 3.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.2 | 4.9 | GO:0009838 | abscission(GO:0009838) |
1.2 | 4.9 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
1.2 | 2.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.2 | 10.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.2 | 4.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.2 | 6.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.2 | 4.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.2 | 9.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
1.2 | 2.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.2 | 4.7 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.2 | 3.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.2 | 1.2 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.2 | 4.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.2 | 2.3 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.1 | 1.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.1 | 8.0 | GO:0050957 | equilibrioception(GO:0050957) |
1.1 | 3.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.1 | 3.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.1 | 5.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.1 | 3.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.1 | 3.3 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.1 | 3.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.1 | 2.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.1 | 6.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.1 | 1.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.1 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.1 | 3.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.1 | 3.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.1 | 2.1 | GO:0036166 | phenotypic switching(GO:0036166) |
1.0 | 1.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.0 | 1.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.0 | 5.2 | GO:1904970 | brush border assembly(GO:1904970) |
1.0 | 13.6 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
1.0 | 6.2 | GO:0060613 | fat pad development(GO:0060613) |
1.0 | 2.0 | GO:0015677 | copper ion import(GO:0015677) |
1.0 | 5.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.0 | 3.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.0 | 1.0 | GO:0060214 | endocardium formation(GO:0060214) |
1.0 | 10.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
1.0 | 8.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.0 | 5.1 | GO:0015879 | carnitine transport(GO:0015879) |
1.0 | 3.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.0 | 4.0 | GO:0043174 | nucleoside salvage(GO:0043174) |
1.0 | 3.0 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.0 | 5.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.0 | 2.0 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.0 | 2.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.0 | 2.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.0 | 2.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.0 | 1.0 | GO:0070339 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
1.0 | 1.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.0 | 2.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.0 | 3.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.0 | 1.9 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
1.0 | 2.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.0 | 2.9 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.9 | 3.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.9 | 2.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.9 | 5.7 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.9 | 13.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.9 | 4.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.9 | 1.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.9 | 14.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.9 | 3.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.9 | 2.8 | GO:0060618 | nipple development(GO:0060618) |
0.9 | 4.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.9 | 2.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 4.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.9 | 2.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.9 | 2.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.9 | 1.9 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.9 | 3.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.9 | 2.8 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.9 | 1.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.9 | 2.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.9 | 2.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.9 | 3.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.9 | 1.8 | GO:0002215 | defense response to nematode(GO:0002215) |
0.9 | 1.8 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.9 | 6.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 1.8 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.9 | 5.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.9 | 7.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.9 | 2.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.9 | 5.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.9 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.9 | 1.8 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.9 | 3.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.9 | 2.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.9 | 1.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.9 | 0.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.9 | 0.9 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.9 | 1.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 15.7 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.9 | 2.6 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.9 | 2.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.9 | 1.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.9 | 2.6 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.8 | 2.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.8 | 2.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.8 | 10.2 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.8 | 5.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.8 | 1.7 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.8 | 4.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.8 | 0.8 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
0.8 | 3.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 0.8 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.8 | 2.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.8 | 1.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.8 | 3.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.8 | 8.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.8 | 1.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.8 | 14.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.8 | 0.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.8 | 3.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 4.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.8 | 0.8 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.8 | 5.7 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.8 | 1.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.8 | 1.6 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.8 | 0.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.8 | 7.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.8 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 0.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.8 | 2.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 0.8 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.8 | 8.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 6.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.8 | 1.6 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.8 | 2.3 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.8 | 3.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.8 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.8 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 3.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.8 | 0.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.8 | 0.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 6.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.8 | 1.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.8 | 3.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 19.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.8 | 5.3 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.8 | 2.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 3.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.8 | 3.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.8 | 3.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.8 | 0.8 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.8 | 2.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.8 | 2.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 4.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.7 | 3.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.7 | 8.9 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.7 | 3.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.7 | 3.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 2.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 2.2 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 2.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.7 | 2.9 | GO:0097286 | iron ion import(GO:0097286) |
0.7 | 1.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.7 | 0.7 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 2.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 1.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.7 | 6.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.7 | 10.2 | GO:0043486 | histone exchange(GO:0043486) |
0.7 | 5.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 1.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 0.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.7 | 1.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.7 | 1.4 | GO:0010042 | response to manganese ion(GO:0010042) |
0.7 | 3.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.7 | 1.4 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.7 | 1.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.7 | 0.7 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.7 | 4.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.7 | 4.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.7 | 2.1 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.7 | 2.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.7 | 2.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.7 | 2.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.7 | 16.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 3.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.7 | 1.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.7 | 0.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 0.7 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.7 | 8.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.7 | 4.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 2.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.7 | 2.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.7 | 2.6 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.7 | 2.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.7 | 1.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.7 | 0.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.7 | 3.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 3.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.7 | 0.7 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.6 | 1.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.6 | 2.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 3.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.6 | 3.9 | GO:0060416 | response to growth hormone(GO:0060416) |
0.6 | 6.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.6 | 4.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 1.9 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.6 | 16.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.6 | 1.9 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.6 | 2.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 3.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.6 | 12.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.6 | 2.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.6 | 5.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.6 | 1.9 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.6 | 1.9 | GO:0000050 | urea cycle(GO:0000050) |
0.6 | 3.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.6 | 3.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 12.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.6 | 2.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 1.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.6 | 9.9 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.6 | 4.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 3.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.6 | 2.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 2.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.6 | 4.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 1.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 1.2 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.6 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 4.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.6 | 2.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.6 | 0.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.6 | 4.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 1.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.6 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 0.6 | GO:0061724 | lipophagy(GO:0061724) |
0.6 | 4.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.6 | 4.2 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.6 | 1.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 2.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 1.8 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.6 | 1.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.6 | 2.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.6 | 1.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.6 | 1.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.6 | 0.6 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.6 | 1.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.6 | 2.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 2.9 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 1.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.6 | 2.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 1.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 0.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.6 | 1.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 0.6 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.6 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 8.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 1.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 2.3 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 2.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.6 | 3.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 2.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 14.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.6 | 3.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 0.6 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.6 | 6.1 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.5 | 2.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.5 | 2.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.5 | 15.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 7.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.5 | 12.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 0.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 1.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.5 | 0.5 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.5 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 7.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 1.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 1.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 1.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 4.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.5 | 2.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 3.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 2.6 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 3.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 0.5 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.5 | 4.7 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.5 | 2.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 1.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 11.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.5 | 1.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.5 | 2.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 1.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 0.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.5 | 2.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 4.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 3.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 2.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 1.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.5 | 2.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 2.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 2.0 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.5 | 1.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 7.0 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.5 | 1.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 2.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 1.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.5 | 1.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.5 | 2.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 3.0 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 0.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.5 | 2.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.5 | 1.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 1.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.5 | 1.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.5 | 3.4 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.5 | 1.9 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.5 | 6.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 1.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.5 | 1.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 1.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.5 | 6.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.5 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.5 | 2.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 1.4 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.5 | 1.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.5 | 1.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.5 | 1.4 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.5 | 4.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.5 | 7.6 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 1.9 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) |
0.5 | 0.5 | GO:0045472 | response to ether(GO:0045472) |
0.5 | 0.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) negative regulation of gastrulation(GO:2000542) |
0.5 | 3.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 0.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.5 | 0.5 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.5 | 0.5 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.5 | 1.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.5 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.5 | 1.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 0.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 1.9 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.5 | 2.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.5 | 2.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.5 | 0.5 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.5 | 1.4 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 2.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.5 | 0.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 1.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 8.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 0.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 1.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 2.3 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.5 | 1.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 0.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 5.0 | GO:0017144 | drug metabolic process(GO:0017144) |
0.5 | 0.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 1.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 4.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 0.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.4 | 1.8 | GO:0060242 | contact inhibition(GO:0060242) |
0.4 | 0.9 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 1.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 5.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 4.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 3.5 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.4 | 1.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 0.9 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 0.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 1.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 2.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 1.7 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 1.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.3 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.4 | 2.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 0.4 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.4 | 7.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 3.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.4 | 3.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 2.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.4 | 18.7 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.4 | 2.1 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 6.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.4 | 0.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 0.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 4.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 2.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.4 | 5.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 5.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.4 | 0.4 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.4 | 2.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 1.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 5.8 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.4 | 0.8 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.4 | 20.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.4 | 2.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 0.8 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.4 | 1.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.4 | 1.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.4 | 0.8 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 1.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 8.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 3.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 3.3 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.4 | 4.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 2.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 1.2 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.4 | 2.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 12.9 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.4 | 2.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 2.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 2.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 4.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.8 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 1.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 0.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 1.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 1.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.4 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 0.8 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.4 | 1.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.4 | 6.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 0.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 4.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 0.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 2.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 0.4 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.4 | 0.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.4 | 0.8 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.4 | 6.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 0.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.4 | 1.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.4 | 0.4 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.4 | 3.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 1.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 0.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.8 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 0.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) negative regulation of fatty acid metabolic process(GO:0045922) |
0.4 | 1.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 0.8 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 2.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.4 | 1.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.4 | 1.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.4 | 3.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.4 | 0.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 1.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.4 | 0.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.4 | 1.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 1.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 3.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 1.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 2.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 1.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.4 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.4 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.4 | 1.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.4 | 4.0 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.4 | 1.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 4.0 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.4 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.4 | 6.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.4 | 4.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 1.5 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.4 | 0.4 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.4 | 2.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 0.4 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) modulation by symbiont of host molecular function(GO:0052055) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.4 | 1.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.4 | 2.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 2.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 1.8 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.4 | 1.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 2.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 1.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 2.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 4.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.4 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 1.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 1.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 0.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 1.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.4 | 6.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 1.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.4 | 1.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.4 | 0.4 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.4 | 3.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.4 | 2.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 1.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.4 | 2.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.4 | 1.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.4 | 1.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.3 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.3 | 3.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 2.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 1.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 2.1 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.3 | 3.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 0.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 1.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 1.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 5.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 1.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.3 | 2.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 1.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 0.7 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 3.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 0.7 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.3 | 5.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.3 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.3 | 2.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.3 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 1.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 1.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 8.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 1.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 5.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.3 | 2.9 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.3 | 1.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 3.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 3.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.3 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 7.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 7.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 2.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 2.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 1.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 0.9 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.3 | 0.3 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 6.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.3 | 1.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 0.9 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 2.2 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 1.9 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.6 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 2.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 4.6 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.3 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 4.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 4.9 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.3 | 0.6 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 4.2 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 1.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 1.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 1.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.3 | 0.6 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.3 | 1.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 1.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 2.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 0.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 12.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 2.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 6.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 0.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 1.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 9.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 2.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 1.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 5.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.3 | 0.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.3 | 0.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 0.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 0.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 1.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 1.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 1.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 | 1.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 1.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.3 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.3 | 1.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 1.7 | GO:0001706 | endoderm formation(GO:0001706) |
0.3 | 1.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 5.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 2.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 1.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 1.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.3 | 1.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.6 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 1.1 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.3 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 0.3 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.3 | 1.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 0.5 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.3 | 1.9 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.3 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.3 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 0.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 2.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 1.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.3 | 0.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 0.8 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 0.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 3.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.3 | 0.8 | GO:2001268 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 0.8 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 6.0 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.3 | 2.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 0.5 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.3 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 0.5 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.3 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.8 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 0.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 2.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 0.3 | GO:0090656 | t-circle formation(GO:0090656) |
0.3 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 1.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.3 | 2.6 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.3 | 1.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 0.5 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.3 | 1.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 0.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.3 | 1.5 | GO:0006228 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
0.2 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 1.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.2 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 0.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 1.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 2.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 3.4 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 1.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 1.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.2 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.7 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 1.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 1.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.9 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.9 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.2 | 2.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 1.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.5 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.5 | GO:0043144 | snoRNA processing(GO:0043144) |
0.2 | 2.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 6.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.9 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 3.9 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 2.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.2 | 0.9 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 0.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.2 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.2 | 0.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.8 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.2 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.2 | 1.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 2.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.7 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 2.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 7.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 3.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 5.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 1.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 0.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 5.7 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 1.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.2 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 13.2 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.2 | 0.4 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 1.9 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 1.0 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 0.2 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
0.2 | 0.6 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 | 3.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.2 | 0.2 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.2 | 4.3 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 3.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 1.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 1.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.6 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.2 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.6 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 1.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.4 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 1.0 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.2 | 0.8 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 1.0 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 1.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 3.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 1.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.2 | 0.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.2 | 0.8 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 2.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.2 | GO:0042092 | type 2 immune response(GO:0042092) |
0.2 | 0.9 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 2.9 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
0.2 | 0.2 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 1.3 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.7 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 3.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 1.4 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.2 | 2.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 0.7 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.2 | 1.6 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 0.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.9 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.2 | 0.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 1.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.5 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.2 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.0 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.3 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.2 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 3.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 6.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.2 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 1.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 1.8 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.2 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.2 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 5.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 0.3 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.2 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) negative regulation of cardiac muscle contraction(GO:0055118) |
0.2 | 0.5 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.2 | GO:0032528 | microvillus organization(GO:0032528) |
0.2 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.5 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 2.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 1.0 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.2 | 0.5 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.3 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 3.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 1.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 1.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 1.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 1.3 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.1 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) |
0.1 | 0.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 1.0 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 2.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 1.9 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 12.8 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 1.2 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 2.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 2.3 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 1.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 3.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.8 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0033032 | regulation of myeloid cell apoptotic process(GO:0033032) |
0.1 | 1.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.8 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 7.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.5 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 1.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.5 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 4.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 2.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.4 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 5.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 2.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.4 | GO:0071554 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 1.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.5 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.9 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.1 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.2 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 2.9 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 8.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 3.9 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.9 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.2 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 3.6 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 0.8 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.5 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 3.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 1.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.7 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.6 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.9 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.1 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.5 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 1.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.2 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 2.9 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 2.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.6 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 2.2 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.8 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.7 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 1.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.4 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:1900246 | regulation of RIG-I signaling pathway(GO:0039535) positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.1 | GO:0072537 | fibroblast activation(GO:0072537) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.6 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.6 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.7 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.9 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 2.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.3 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.6 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 2.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.4 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 2.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.3 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.4 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 2.3 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.1 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.1 | 0.8 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 0.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.1 | 0.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 1.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.7 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.1 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 0.4 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 2.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.1 | 0.1 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.1 | 0.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 2.7 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.4 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) inner medullary collecting duct development(GO:0072061) |
0.1 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 1.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.2 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 1.8 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.9 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.2 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.0 | 0.1 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.3 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.3 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.0 | 0.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.4 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.0 | GO:0021571 | pons development(GO:0021548) rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.2 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.1 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 0.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.0 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.7 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.0 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.0 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 1.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.3 | GO:2000107 | negative regulation of leukocyte apoptotic process(GO:2000107) |
0.0 | 0.0 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.0 | 0.1 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 2.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.3 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.3 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.0 | 0.0 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.0 | 0.0 | GO:0034629 | gamma-tubulin complex localization(GO:0033566) cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.0 | 0.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.0 | 0.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.0 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.0 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.0 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0009415 | response to water(GO:0009415) |
0.0 | 0.0 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.0 | 0.0 | GO:0009262 | deoxyribonucleotide metabolic process(GO:0009262) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0072604 | interleukin-6 secretion(GO:0072604) |
0.0 | 0.0 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 16.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.2 | 32.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.8 | 11.3 | GO:0072487 | MSL complex(GO:0072487) |
2.3 | 7.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.0 | 10.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.0 | 9.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.9 | 9.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.9 | 43.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.9 | 5.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.8 | 7.2 | GO:1990130 | Iml1 complex(GO:1990130) |
1.6 | 16.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.5 | 4.4 | GO:0005642 | annulate lamellae(GO:0005642) |
1.4 | 5.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.4 | 15.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.4 | 10.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.3 | 4.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.3 | 4.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.3 | 9.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.3 | 5.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.3 | 5.0 | GO:0035339 | SPOTS complex(GO:0035339) |
1.2 | 8.7 | GO:0090543 | Flemming body(GO:0090543) |
1.2 | 7.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.1 | 2.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.1 | 4.4 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.1 | 3.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.1 | 4.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.1 | 5.3 | GO:0005579 | membrane attack complex(GO:0005579) |
1.0 | 7.3 | GO:0030056 | hemidesmosome(GO:0030056) |
1.0 | 1.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.0 | 6.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.0 | 3.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.0 | 4.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.0 | 6.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 10.8 | GO:0070852 | cell body fiber(GO:0070852) |
1.0 | 5.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.0 | 10.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 4.7 | GO:0005638 | lamin filament(GO:0005638) |
0.9 | 3.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.9 | 2.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.9 | 0.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.9 | 4.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.9 | 6.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 14.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.9 | 6.9 | GO:0045179 | apical cortex(GO:0045179) |
0.9 | 2.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.8 | 49.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.8 | 4.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.8 | 0.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.8 | 4.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 3.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 66.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.8 | 2.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 3.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 2.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 2.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 4.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.7 | 2.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.7 | 4.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 4.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.7 | 1.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.7 | 4.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.7 | 3.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 2.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.6 | 7.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.6 | 17.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.6 | 1.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 5.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 2.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 4.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.6 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 8.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.6 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 2.3 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 1.2 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 4.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.6 | 1.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 18.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 3.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.6 | 2.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.6 | 7.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 2.8 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 4.4 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 2.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 6.5 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 2.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 2.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 1.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 2.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 1.5 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.5 | 1.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 1.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.5 | 3.0 | GO:0005818 | aster(GO:0005818) |
0.5 | 1.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 2.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 3.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 8.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 3.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 1.9 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 1.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 8.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 2.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 5.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.5 | 4.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 3.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 1.8 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 5.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 5.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 3.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 1.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 14.6 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 3.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 3.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 16.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 3.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 3.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 1.6 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 0.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 7.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 2.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 4.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.4 | 1.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.4 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 3.9 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 1.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 3.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 1.1 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 1.5 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 16.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 38.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.4 | 4.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 1.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 3.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 48.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.4 | 1.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 4.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 1.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 2.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 4.8 | GO:0043034 | costamere(GO:0043034) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 10.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 2.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 1.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 1.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 2.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 1.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 6.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 12.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 8.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 4.6 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 20.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 2.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 3.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 1.2 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 30.6 | GO:0005903 | brush border(GO:0005903) |
0.3 | 3.3 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 4.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 1.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 2.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 9.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 0.9 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 5.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 3.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 2.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 4.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 80.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 0.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 0.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 3.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 3.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 3.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 2.8 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 3.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 14.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 4.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 1.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 9.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 5.2 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 4.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 0.8 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.3 | 3.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 0.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 5.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.0 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 1.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 2.9 | GO:0061702 | inflammasome complex(GO:0061702) |
0.2 | 4.9 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 2.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 7.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 5.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 11.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 1.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 7.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 4.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 7.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.2 | 2.0 | GO:0044440 | endosomal part(GO:0044440) |
0.2 | 14.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 1.6 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 1.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 3.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 12.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.2 | 8.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 6.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 4.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.8 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 7.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 3.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 8.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 4.4 | GO:0030894 | replisome(GO:0030894) |
0.2 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.8 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 8.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 2.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 9.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 325.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.7 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 144.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 2.1 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 4.2 | GO:0044452 | nucleolar part(GO:0044452) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 7.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 2.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.8 | GO:0031672 | A band(GO:0031672) |
0.2 | 2.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.2 | 1.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 2.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 2.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 4.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 8.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 1.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.1 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.7 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 20.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.6 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 10.0 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 2.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 116.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 4.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 12.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 5.6 | GO:0044454 | nuclear chromosome part(GO:0044454) |
0.1 | 0.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 6.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 5.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 69.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 10.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 3.2 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.1 | 13.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 19.1 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.3 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.5 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 2.8 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0022624 | proteasome regulatory particle, base subcomplex(GO:0008540) proteasome accessory complex(GO:0022624) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 1.0 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.7 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.0 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 31.2 | GO:0009374 | biotin binding(GO:0009374) |
6.3 | 18.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
3.8 | 15.0 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
3.6 | 10.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
3.4 | 10.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.3 | 13.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.2 | 9.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.0 | 9.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.9 | 2.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.8 | 11.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.7 | 16.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.7 | 10.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.6 | 7.9 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.6 | 7.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.6 | 13.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.5 | 10.0 | GO:0015232 | heme transporter activity(GO:0015232) |
2.3 | 35.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
2.3 | 11.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.3 | 9.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
2.2 | 8.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.2 | 6.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.1 | 6.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.1 | 8.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.9 | 26.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.9 | 7.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.8 | 12.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.8 | 5.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.8 | 7.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.8 | 9.0 | GO:0070061 | fructose binding(GO:0070061) |
1.8 | 7.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.8 | 5.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.7 | 7.0 | GO:0051425 | PTB domain binding(GO:0051425) |
1.7 | 5.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.7 | 5.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.6 | 9.9 | GO:0008199 | ferric iron binding(GO:0008199) |
1.6 | 6.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.6 | 4.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.5 | 5.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.4 | 7.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.4 | 1.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.4 | 4.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.4 | 8.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.4 | 7.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.3 | 5.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.3 | 6.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.3 | 9.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.3 | 5.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.3 | 6.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.3 | 5.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.2 | 6.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.2 | 3.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.2 | 9.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.2 | 3.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.2 | 4.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.2 | 3.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.1 | 23.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.1 | 3.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.1 | 2.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.1 | 3.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.1 | 10.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.1 | 13.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.1 | 22.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.1 | 7.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.1 | 4.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.1 | 1.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.1 | 3.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.1 | 3.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.0 | 3.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.0 | 3.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.0 | 4.2 | GO:0038100 | nodal binding(GO:0038100) |
1.0 | 3.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.0 | 4.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.0 | 4.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.0 | 3.9 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.0 | 22.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 2.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.0 | 7.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.0 | 8.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.0 | 4.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 2.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 13.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.0 | 5.8 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.0 | 11.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.0 | 2.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.9 | 2.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 1.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 16.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.9 | 5.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.9 | 7.3 | GO:0008430 | selenium binding(GO:0008430) |
0.9 | 5.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.9 | 6.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 3.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.9 | 2.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.9 | 4.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.9 | 2.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.9 | 1.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 8.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.9 | 1.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.8 | 2.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 12.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 6.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.8 | 1.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.8 | 15.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.8 | 2.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.8 | 2.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 4.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.8 | 11.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.8 | 2.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.8 | 4.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.8 | 8.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.8 | 2.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 3.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 2.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 2.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.8 | 7.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 2.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 3.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.8 | 0.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.8 | 6.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.7 | 4.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.7 | 1.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.7 | 5.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 4.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.7 | 5.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.7 | 3.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 9.4 | GO:0019825 | oxygen binding(GO:0019825) |
0.7 | 8.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 2.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.7 | 3.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 3.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 4.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.7 | 2.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.7 | 0.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.7 | 2.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 2.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.7 | 8.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.7 | 1.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.7 | 2.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.7 | 4.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 1.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.7 | 6.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 2.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 2.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 7.2 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.6 | 20.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.6 | 2.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 5.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.6 | 11.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 5.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 3.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 2.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 2.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.6 | 1.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.6 | 3.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 3.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.6 | 4.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.6 | 6.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.6 | 9.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 3.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 9.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 0.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 1.8 | GO:0032564 | dATP binding(GO:0032564) |
0.6 | 5.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 5.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.6 | 10.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 9.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 2.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 4.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 4.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 1.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 2.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 1.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 6.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 1.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.6 | 3.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 1.7 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 2.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.6 | 2.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.6 | 17.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.6 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 7.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 2.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.5 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 1.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 2.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 5.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 2.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 13.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.5 | 1.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 30.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 1.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 5.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 2.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 2.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 4.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.5 | 1.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.5 | 2.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 2.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.5 | 0.5 | GO:0048020 | CCR5 chemokine receptor binding(GO:0031730) CCR chemokine receptor binding(GO:0048020) |
0.5 | 4.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 3.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 3.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 0.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.5 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 2.5 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 1.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 1.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 4.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 2.4 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 1.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 0.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.5 | 1.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 1.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 53.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.5 | 0.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 0.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 3.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 2.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 3.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 2.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.5 | 13.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 4.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.5 | 2.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.5 | 2.3 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 5.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 2.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 2.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 3.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 3.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 3.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 11.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 25.8 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 1.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 41.5 | GO:0002020 | protease binding(GO:0002020) |
0.4 | 1.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 3.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 7.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 6.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.4 | 1.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.4 | 2.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 2.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 3.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 1.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 2.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 1.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 3.7 | GO:0046977 | TAP binding(GO:0046977) |
0.4 | 3.3 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 1.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 2.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 1.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.4 | 1.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.0 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.4 | 2.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 4.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 2.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 2.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 4.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 7.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.4 | 0.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.4 | 1.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.4 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 0.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.4 | 5.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 5.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 2.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 0.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 0.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 1.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 0.4 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.4 | 2.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.4 | 6.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 0.7 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.3 | 2.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 1.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 1.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 3.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 20.1 | GO:0020037 | heme binding(GO:0020037) |
0.3 | 3.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.4 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 6.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 9.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 3.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 1.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.3 | 48.5 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.3 | 5.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 2.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 5.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 2.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 10.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 3.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 2.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 2.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 3.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 21.7 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.3 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 13.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 2.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 13.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 4.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 2.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 3.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 3.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 1.0 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 3.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 1.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 1.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 3.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 2.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 9.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 5.6 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.2 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 2.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.3 | 6.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 7.3 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.3 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 2.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 2.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 5.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 3.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 0.3 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.3 | 1.4 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.3 | 1.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 8.8 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 10.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 0.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 4.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 7.8 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 18.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.3 | 1.1 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 6.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 1.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 5.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 2.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 0.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 6.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.3 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.5 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 0.8 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 46.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 5.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 4.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 0.5 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 1.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 1.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.8 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.3 | 1.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.5 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 3.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 1.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.7 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 9.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 9.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 2.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 2.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 5.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 4.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 5.0 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 2.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 8.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 3.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 2.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.2 | 1.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 2.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 3.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 37.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 17.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 2.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 14.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 3.9 | GO:0005501 | retinoid binding(GO:0005501) |
0.2 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 3.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.2 | 0.4 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 1.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 4.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 4.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 2.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 1.0 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 10.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 0.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 2.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 1.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.2 | 0.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 2.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 9.9 | GO:0015399 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) ATPase activity, coupled to transmembrane movement of substances(GO:0042626) ATPase activity, coupled to movement of substances(GO:0043492) |
0.2 | 4.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 3.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 5.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 4.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.2 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 7.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 1.8 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 5.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 2.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.6 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 25.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 3.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 5.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 2.8 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 2.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 10.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 4.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 3.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 6.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.9 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.8 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 20.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.1 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 1.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 3.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 3.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 2.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 1.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 1.3 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 4.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 7.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 1.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 20.3 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 1.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 3.2 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 2.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 11.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 1.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.5 | GO:0016160 | amylase activity(GO:0016160) |
0.1 | 2.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 12.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 1.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 1.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.4 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 3.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0034416 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.1 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.1 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 2.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 1.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 2.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 9.8 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 1.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 1.6 | GO:0042623 | ATPase activity, coupled(GO:0042623) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.1 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 2.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 1.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.0 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 24.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.6 | 6.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.1 | 51.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.0 | 17.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.0 | 11.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 7.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.9 | 18.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 36.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.8 | 17.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 11.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 8.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 14.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.7 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 18.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.7 | 24.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 8.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 15.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 72.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 16.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 1.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 5.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.6 | 2.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 5.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 3.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 6.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 5.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 5.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 5.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 24.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 6.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 18.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 9.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 12.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 1.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 10.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 15.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 14.0 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 21.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 4.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 14.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 5.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 3.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 5.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 4.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 3.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 3.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 9.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 4.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 3.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 4.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 7.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 0.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 5.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 6.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 6.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 2.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 5.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 6.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 1.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 3.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 2.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 9.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 7.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 4.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 1.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 3.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 5.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 2.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 5.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 2.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 3.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 18.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.9 | 19.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.8 | 8.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.5 | 13.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.5 | 14.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.4 | 18.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.2 | 8.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.2 | 10.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.1 | 13.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 14.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.0 | 5.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 13.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.9 | 17.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.9 | 9.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.9 | 21.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.9 | 2.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.9 | 8.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 11.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.8 | 16.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 10.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 9.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 7.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 9.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 20.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.8 | 15.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.8 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.8 | 12.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 3.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 10.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 2.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.7 | 23.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 8.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 7.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 7.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.7 | 7.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.7 | 7.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 5.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 7.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 4.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 10.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 6.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 5.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 13.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.6 | 4.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 24.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 15.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 4.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 51.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 9.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 24.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 3.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.5 | 8.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.5 | 9.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 11.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 4.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 17.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.5 | 4.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 6.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 13.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.5 | 17.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.5 | 11.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 6.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 14.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.5 | 5.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 1.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 2.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 4.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 10.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 7.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 0.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 4.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 6.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 5.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.4 | 5.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.4 | 4.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 16.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 5.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 1.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.4 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 1.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.4 | 2.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 11.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 5.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 14.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 5.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 7.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 1.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 6.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 4.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 4.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 21.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 3.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 2.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 5.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 7.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 1.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 9.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 4.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 2.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 1.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 9.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 3.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 27.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 8.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.3 | 1.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 3.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 4.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 1.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 19.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 1.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 4.1 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.3 | 0.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 6.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 5.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 0.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 3.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 9.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 7.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.2 | 2.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 0.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 11.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 3.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 4.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 2.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 6.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 24.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.5 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.2 | 1.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 0.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.2 | 0.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 0.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 3.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 1.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 5.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 2.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.7 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 2.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 3.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 3.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 0.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.2 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.1 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.1 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 0.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.4 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 2.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.2 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.2 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 0.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 1.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 1.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |